drug prices
Coverage of drug prices in the Nexus archive.
- Drug prices have declined sharply, and Trump is taking credit. The reason behind the drop is complex
Donald Trump has promoted new data showing that U.S. prescription drug prices fell 0.8% in July and are down 3.1% compared to a year ago. The title notes that while these drops suggest improvements, the actual reason behind the decline is complex.
- Big pharma warns Germany’s attempts to curb drug prices will backfire
Big pharma has warned that attempts by Germany to curb drug prices may backfire. Conversely, a government source stated that implementing higher mandatory discounts for insurers is predicted to save €12bn by 2030.
- Trump shows off article on lower drug prices that says Biden deserves credit, not him
The White House shared an image of Donald Trump displaying a Washington Post headline reporting that prescription drug prices saw their sharpest drop in more than 60 years. However, the content notes that experts cited within the article actually attributed this significant price decrease to Joe Biden, rather than Trump.
- ‘Bureaucratic inertia’: Delaware lawmaker says state board should pursue more aggressive reforms to drive down employee drug prices
A Delaware lawmaker prompted the General Assembly to mandate reforms regarding how state drug benefits are negotiated with Pharmacy Benefit Managers (PBMs). The State Employee Benefits Committee was tasked with examining ways to increase transparency and reduce hidden costs in this process. The reformer argued that requiring PBMs to supply detailed pricing data, rebates, and contract information is necessary for the state to better manage its group health insurance plan.
- States Seek to Lower Drug Prices by Targeting Pharmacy Benefit Managers
States are attempting to reduce drug prices by regulating pharmacy benefit managers, which manage prescription coverage for health insurers. The move addresses consumer concerns about rising medication costs.
- US launches investigation into drug prices in Germany, risking renewed tensions with Europe
The US has launched an investigation into drug prices in Germany, risking renewed tensions with Europe. Robert Kennedy Jr., US Secretary of Health, and President Donald Trump announced this at a press conference at the White House.